Candriam S.C.A. Castle Biosciences Inc Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$19.47 - $28.49 $287,825 - $421,167	-14,783 Reduced 39.32%	22,812 $518,000
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $57,349 - $95,160	3,172 Added 9.21%	37,595 $884,000
Q3 2022 Nov 10, 2022	BUY	$22.51 - $34.32 $774,861 - $1.18 Million	34,423 New	34,423 $898,000

201

24.5M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $656M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.